Modulating carbonyl cytotoxicity in intact rat hepatocytes by inhibiting carbonyl metabolizing enzymes. II. Aromatic aldehydes. 2003

Hossein Niknahad, and Adam Shuhendler, and Giuseppe Galati, and Arno G Siraki, and Elaine Easson, and Raymond Poon, and Peter J O'Brien
Faculty of Pharmacy, Department of Pharmacology and Toxicology, Shiraz University of Medical Sciences, Shiraz, 71345, Fars, Iran.

The molecular cytotoxic mechanisms of dietary benzaldehydes towards hepatocytes and its modulation by metabolizing enzymes were compared. Salicylaldehyde was found to be the most cytotoxic followed by cinnamaldehyde and both rapidly depleted some glutathione before an inhibition of respiration occurred, which preceded cell lysis. Reactive oxygen species were formed, but lipid peroxidation was induced with cinnamaldehyde, but not salicylaldehyde. Glutathione depleted hepatocytes were more susceptible to cytotoxicity. Mitochondrial toxicity and cytotoxicity were prevented by glycolytic substrates (e.g. fructose), citric acid cycle substrates (e.g. glutamine) or cyclosporin, the mitochondrial permeability transition inhibitor. Inhibition of mitochondrial ALDH with chloral hydrate, crotonaldehyde or citral or decreasing mitochondrial NAD+ with rotenone increased cinnamaldehyde induced cytotoxicity with a much smaller effect on salicylaldehyde induced cytotoxicity. Cyanamide was the most effective ALDH inhibitor for increasing cinnamaldehyde induced cytotoxicity, presumably because cyanamide also inhibits microsomal ALDH. Although cinnamaldehyde was a better substrate than salicylaldehyde for ADH1, cytosolic NADH generators (e.g. xylitol) prevented salicylaldehyde and cinnamaldehyde cytotoxicity similarly. This could be explained as salicylaldehyde was not a substrate for the ALDHs and would then be more dependent on ADH for detoxification.

UI MeSH Term Description Entries
D008297 Male Males
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D000444 Aldehyde Dehydrogenase An enzyme that oxidizes an aldehyde in the presence of NAD+ and water to an acid and NADH. This enzyme was formerly classified as EC 1.1.1.70. D-Glucuronolactone Dehydrogenase,Aldehyde Dehydrogenase (NAD(+)),Aldehyde Dehydrogenase E1,Aldehyde Dehydrogenase E2,Aldehyde-NAD Oxidoreductase,Aldehyde NAD Oxidoreductase,D Glucuronolactone Dehydrogenase,Dehydrogenase, Aldehyde,Dehydrogenase, D-Glucuronolactone
D000447 Aldehydes Organic compounds containing a carbonyl group in the form -CHO. Aldehyde
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D022781 Hepatocytes The main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules. Hepatic Cells,Cell, Hepatic,Cells, Hepatic,Hepatic Cell,Hepatocyte

Related Publications

Hossein Niknahad, and Adam Shuhendler, and Giuseppe Galati, and Arno G Siraki, and Elaine Easson, and Raymond Poon, and Peter J O'Brien
May 2011, Chemico-biological interactions,
Hossein Niknahad, and Adam Shuhendler, and Giuseppe Galati, and Arno G Siraki, and Elaine Easson, and Raymond Poon, and Peter J O'Brien
December 1953, The Journal of biological chemistry,
Hossein Niknahad, and Adam Shuhendler, and Giuseppe Galati, and Arno G Siraki, and Elaine Easson, and Raymond Poon, and Peter J O'Brien
February 2019, Chemico-biological interactions,
Hossein Niknahad, and Adam Shuhendler, and Giuseppe Galati, and Arno G Siraki, and Elaine Easson, and Raymond Poon, and Peter J O'Brien
November 1990, In vitro cellular & developmental biology : journal of the Tissue Culture Association,
Hossein Niknahad, and Adam Shuhendler, and Giuseppe Galati, and Arno G Siraki, and Elaine Easson, and Raymond Poon, and Peter J O'Brien
April 1994, Cell biology and toxicology,
Hossein Niknahad, and Adam Shuhendler, and Giuseppe Galati, and Arno G Siraki, and Elaine Easson, and Raymond Poon, and Peter J O'Brien
January 1999, Advances in experimental medicine and biology,
Hossein Niknahad, and Adam Shuhendler, and Giuseppe Galati, and Arno G Siraki, and Elaine Easson, and Raymond Poon, and Peter J O'Brien
December 1995, Biological & pharmaceutical bulletin,
Hossein Niknahad, and Adam Shuhendler, and Giuseppe Galati, and Arno G Siraki, and Elaine Easson, and Raymond Poon, and Peter J O'Brien
May 1994, Biochemical Society transactions,
Hossein Niknahad, and Adam Shuhendler, and Giuseppe Galati, and Arno G Siraki, and Elaine Easson, and Raymond Poon, and Peter J O'Brien
March 1996, European journal of biochemistry,
Hossein Niknahad, and Adam Shuhendler, and Giuseppe Galati, and Arno G Siraki, and Elaine Easson, and Raymond Poon, and Peter J O'Brien
September 1998, Acta pharmaceutica Hungarica,
Copied contents to your clipboard!